Plain-English translation of NCT06910670 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new web-based decision tool designed to help patients with rare cancers—specifically cholangiocarcinoma, colorectal cancer, and multiple myeloma—understand and choose which types of genetic results they would like to receive from genetic testing. The study compares this new tool to the standard informed consent process to see which approach helps patients make better decisions about their genetic information.
Many patients feel overwhelmed when deciding what genetic information they want to learn about themselves. This tool was created to make that decision clearer and easier, especially for people with less common cancers who may have fewer resources available to help them understand their genetic testing options.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of two groups. One group will use the new web-based decision tool to explore and choose which genetic results they want to receive; the other group will receive the standard written information about genetic results. Both groups will make their choices online, and the study team will compare how well each approach helps patients feel informed and confident in their decisions.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States